Patrick Soon-Shiong

Patrick Soon-Shiong (born July 29, 1952) is a South African and American businessman, investor, medical researcher, and transplant surgeon. He is the inventor of the drug Abraxane, which is used for lung, breast, and pancreatic cancer. Soon-Shiong is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at Imperial College London and Dartmouth College.

Soon-Shiong is the chairman of three nonprofit organizations: the Chan Soon-Shiong Family Foundation, a research-funding foundation that works in health care and education accessibility; the Chan Soon-Shiong Institute for Advanced Health, which aims to change the dissemination of healthcare information; and the Healthcare Transformation Institute, a partnership with the University of Arizona and Arizona State University. He has been a minority owner of the Los Angeles Lakers since 2010, and since June 2018, he has been the owner and executive chairman of the ''Los Angeles Times''.

Soon-Shiong's net worth is US$11.3 billion as of 2025 according to Bloomberg Billionaires Index. He has been called the richest man in Los Angeles and one of the wealthiest doctors in the world. Provided by Wikipedia